Showing results (221-230 of 569) with videos related to

Sort By:
Pageof 57
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A ReappraisalJoanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, et al.
Cancer Research|November 3, 2006
Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer riskXianshu Wang, Fengwei Wang, Ken Taniguchi, et al.
American Journal of Human Genetics|September 24, 2024
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variantsMarcy E Richardson, Megan Holdren, Terra Brannan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 22, 2020
Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significancePaulo C M Lyra, Thales C Nepomuceno, Marcele L M de Souza, et al.
BMC Cancer|October 8, 2014
ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancerJordan M Reese, Vera J Suman, Malayannan Subramaniam, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|February 18, 2010
Variation at 8q24 and 9p24 and risk of epithelial ovarian cancerKristin L White, Thomas A Sellers, Brooke L Fridley, et al.
Journal of the National Cancer Institute|November 15, 2007
Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancerAlison M Hosey, Julia J Gorski, Margaret M Murray, et al.
Breast Cancer Research and Treatment|November 23, 2006
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifenMatthew P Goetz, Stacey K Knox, Vera J Suman, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2021
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapyJenny Furlanetto, Volker Möbus, Andreas Schneeweiss, et al.
Pageof 57